Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
Pollack VA, Alvarez E, Tse KF, Torgov MY, Xie S, Shenoy SG, MacDougall JR, Arrol S, Zhong H, Gerwien RW, Hahne WF, Senter PD, Jeffers ME, Lichenstein HS, LaRochelle WJ.
Pollack VA, et al. Among authors: gerwien rw.
Cancer Chemother Pharmacol. 2007 Aug;60(3):423-35. doi: 10.1007/s00280-007-0490-z. Epub 2007 Jun 1.
Cancer Chemother Pharmacol. 2007.
PMID: 17541593